查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1677252

生物活性胜肽市场按产品类型、来源、製造流程、功能、销售管道和应用划分 - 2025-2030 年全球预测

Bioactive Peptides Market by Type, Source, Production Process, Function, Sales Channel, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2024年生物活性胜肽市值将达47.4亿美元，2025年成长至51.5亿美元，复合年增长率为8.84%，到2030年将达到78.8亿美元。

主要市场统计数据
基准年 2024 年 47.4亿美元
预计 2025 年 51.5亿美元
预测年份 2030 78.8亿美元
复合年增长率（%） 8.84％

活性胜肽已成为功能成分领域的关键成分，重新定义了其在各行业中的应用。近年来，越来越多注重健康保健的消费者开始关注不仅具有营养价值而且还能积极支持生理功能的化合物。生物活性胜肽主要来自食物蛋白质，目前已认识到其具有促进心血管健康、调节免疫反应和在多种治疗应用中充当有效生物活性剂的潜力。

市场受到多种因素的影响，包括科学突破、不断发展的製造技术以及对胜肽功能潜在机制的更深入了解。随着持续的研究推动创新，各公司已经开始将生物活性胜肽整合到从膳食补充剂到药品等产品配方中。技术、有针对性的研发投资以及对自然健康解决方案日益增长的认识的融合，正在创造一个成长和竞争差异化的环境。

这篇介绍文章将深入探讨市场动态、细分策略以及塑造这一变革性产业的区域和企业见解。以下叙述不仅旨在告知，还旨在为行业领导者和相关人员提供了解复杂的生物活性肽领域所需的可靠资料和深思熟虑的分析。

改变生物活性胜肽模式的变革

受生物技术的快速进步和客户期望不断变化推动，生物活性胜肽市场格局正在发生重大变革时期。曾经充满挑战的法规环境现在正在适应创新产品、加速市场进入和促进全球合作。这项变更得益于对研发的大量投资，旨在解锁生物活性胜肽的新应用和性能特性。

这项变化的一个强大催化剂是整合可提高产量和纯度的先进生物加工技术。製造商正在采用酶水解和重组生产等技术，这些技术不仅具有成本效益，而且具有扩充性。这些创新製程日益取代传统的化学合成方法，使生产方法符合现代永续性目标和更严格的品管措施。

此外，消费者需求和监管变化之间的相互作用迫使公司重新考虑其产品开发策略。透明度和可追溯性变得越来越重要，特别是在动物、乳製品、海洋和植物来源肽领域。这些竞争因素正在重新定义市场竞争基准，并迫使市场相关人员重新评估其市场进入方式。这段变革时期时期的另一个特征是数位参与度的爆炸性成长，改变了产品的行销和分销方式。随着传统销售管道的发展，线上平台已成为焦点，品牌网站和电子商务对于接触更多人群至关重要。摘要，该行业正在快速发展，需要不断创新和适应性策略才能在充满活力且不断变化的市场环境中保持竞争力。

推动市场成长的关键细分市场分析

详细的細項分析揭示了生物活性胜肽市场的方面，每个方面都对整体成长做出了独特的贡献。根据类型，市场分为内源性胜肽和外源性胜肽，从而允许公司根据来源效力和所需的生物活性来定制其产品。从来源方面来看，市场可以进一步区分为动物源胜肽、乳製品源胜肽、海洋源胜肽和植物来源肽等类别。

深入研究生产过程，市场正在受益于化学合成、酶水解和重组生产等创新方法。这些方法不仅决定了成本结构和可扩展性，还影响活性化合物的纯度和产量。胜肽的功能特性在细分中也很重要，抗高血压、抗菌、抗氧化和免疫调节等特性构成了有针对性的产品开发的基础。对功能的关注确保市场上的解决方案能够满足临床需求和消费者的健康重点。

销售管道细分为线下商店和快速成长的线上市场，进一步细分为品牌网站和电子商务平台。分销网络的演变是由消费行为的改变和数位优先方法所推动的。最后，活性胜肽在化妆品、机能性食品、营养保健品和药品中的主要应用进一步使市场多样化。整合如此多样化的细分标准，为相关人员提供了跨不同管道和产品细分的价值创造点和策略机会的全面视角。

目录

第 1 章 简介

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 提高消费者对胜肽抗衰老特性的认识
      • 人们对皮肤健康的认识不断提高，推动了对含有生物活性胜肽的产品的需求。
      • 政府法规促进安全有效的护肤成分
    • 限制因素
      • 与高生产成本和复杂製造流程相关的担忧
    • 机会
      • 与皮肤科医生合作，科学验证活性胜肽的美容效果
      • 扩大生物活性胜肽在护髮产品中的应用，以促进头皮健康和头髮再生
    • 任务
      • 活性胜肽采购及加工相关环境问题
  • 市场区隔分析
    • 类型：人们对膳食补充剂的兴趣日益浓厚，导致外源肽的采用率增加
    • 应用：拓展活性胜肽在医药领域的应用
  • 波特五力分析
  • PESTEL 分析
    • 政治的
    • 经济
    • 社会的
    • 技术的
    • 合法的
    • 环境

第六章 生物活性胜肽市场依类型

  • 固有的
  • 外生的

第七章 生物活性胜肽市场（依来源）

  • 动物来源
  • 乳製品
  • 海洋起源
  • 植物来源

第 8 章。

  • 化学合成
  • 酵素水解
  • 重组生产

第九章 生物活性胜肽市场（依功能）

  • 抗高血压药物
  • 抗菌
  • 抗氧化剂
  • 免疫调节

第 10 章。

  • 离线
  • 在线的
    • 品牌网站
    • 电子商务网站

第 11 章 生物活性胜肽市场（依应用）

  • 化妆品
  • 机能性食品
  • 营养补充品
  • 药品

第 12 章美洲生物活性胜肽市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

13. 亚太地区生物活性胜肽市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第 14 章欧洲、中东和非洲生物活性胜肽市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章 竞争格局

  • 2024 年市场占有率分析
  • FPNV 定位矩阵，2024 年
  • 竞争情境分析
  • 战略分析与建议

公司列表

  • Abbott Laboratories
  • Ajinomoto Co., Inc.
  • Amgen Inc.
  • Archer Daniels Midland Company
  • Ashland Inc.
  • Bachem Holding AG
  • BASF SE
  • Cargill, Inc.
  • Clariant AG
  • CPC Scientific Inc.
  • Croda International Plc
  • Eli Lilly and Company'
  • Evonik Industries AG
  • Ferring Pharmaceuticals
  • GenScript Biotech Corporation
  • Givaudan
  • Glanbia plc
  • Koninklijke DSM NV
  • LipoTrue SL
  • Lonza Group
  • Merck & Co., Inc.
  • Novo Nordisk A/S
  • Novozymes A/S
  • PeptiDream Inc.
  • Pfizer Inc.
  • PolyPeptide Group
  • Protagonist Therapeutics, Inc.
  • Roquette Freres
  • Symrise AG
  • Zealand Pharma
Product Code: MRR-094390F3FF55

The Bioactive Peptides Market was valued at USD 4.74 billion in 2024 and is projected to grow to USD 5.15 billion in 2025, with a CAGR of 8.84%, reaching USD 7.88 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 4.74 billion
Estimated Year [2025] USD 5.15 billion
Forecast Year [2030] USD 7.88 billion
CAGR (%) 8.84%

Bioactive peptides have emerged as pivotal components within the arena of functional ingredients, redefining applications across various industries. In recent years, the increasing consumer emphasis on health and wellness has drawn attention to compounds that not only offer nutritional benefits but also actively support physiological functions. Bioactive peptides, derived primarily from food proteins, are now recognized for their potential in promoting cardiovascular health, modulating immune responses, and acting as effective bioactive agents in diverse therapeutic applications.

The market is influenced by a blend of factors including scientific breakthroughs, evolving manufacturing techniques, and a deeper understanding of the underlying mechanisms of peptide functionality. With ongoing research fueling innovation, companies have begun to integrate bioactive peptides in product formulations spanning from nutraceuticals to pharmaceuticals. The convergence of technology, targeted R&D investments, and an increased awareness about natural health solutions has created an environment ripe for growth and competitive differentiation.

This introduction sets the stage for an in-depth exploration of market dynamics, segmentation strategies, and regional as well as corporate insights that are shaping this transformative field. The narrative that follows is designed not only to inform but also to empower industry leaders and stakeholders with robust data and thoughtful analysis necessary to navigate the complex landscape of bioactive peptides.

Transformative Shifts Shaping the Bioactive Peptides Landscape

The landscape of the bioactive peptides market is undergoing significant transformation, driven by rapid advancements in biotechnology and evolving customer expectations. Regulatory environments that once posed challenges are now adapting to accommodate innovative products, thereby accelerating market entry and fostering global collaborations. This shift is underpinned by substantial investments in research and development, which are unlocking new applications and performance characteristics for bioactive peptides.

One of the strongest catalysts for these changes is the integration of advanced bioprocessing techniques that enhance both yield and purity. Manufacturers have embraced techniques such as enzymatic hydrolysis and recombinant production, which are not only cost effective but also scalable. These innovative processes are replacing traditional chemical synthesis methods, thereby aligning production practices with modern sustainability goals and stricter quality control measures.

Moreover, the interplay between consumer demand and regulatory shifts is compelling companies to rethink product development strategies. There is a growing emphasis on transparency and traceability, particularly within the realms of animal-derived, dairy-sourced, marine-derived, and plant-based peptides. Such critical factors are redefining competitive benchmarks and are prompting market players to reevaluate their go-to-market approaches. This time of transformation is also characterized by a surge in digital engagement, altering the way products are marketed and distributed. As traditional sales channels evolve, online platforms have taken center stage, with brand websites and e-commerce becoming essential for reaching a broader audience. In summary, the sector is evolving at a pace that demands continuous innovation and adaptive strategies to stay competitive in a vibrant, fast-changing market environment.

Key Segmentation Insights Driving Market Growth

A detailed segmentation analysis reveals the multi-faceted dimensions of the bioactive peptides market, each contributing uniquely to overall growth. The market is classified based on type into endogenous and exogenous peptides, allowing companies to tailor products based on source efficacy and desired bioactivity. Examination of the source aspect further differentiates the market using categories such as animal derived, dairy sourced, marine-derived, and plant-based peptides, each exhibiting distinct advantages in terms of formulation flexibility and consumer acceptance.

Delving into the production process, the market benefits from innovative approaches including chemical synthesis, enzymatic hydrolysis, and recombinant production. These methods not only define the cost structure and scalability but also influence the purity and yield of active compounds. The functional attributes of peptides are also critical in segmentation, where roles such as antihypertensive, antimicrobial, antioxidant, and immunomodulatory activities form the basis for targeted product development. This specific focus on functionality ensures that market solutions meet clinical needs and consumer health priorities.

Sales channel segmentation adds an additional layer of insight, distinguishing between offline outlets and the rapidly growing online market, which itself is further refined into brand websites and e-commerce platforms. This evolving distribution network is a consequence of shifting consumer behaviors and a digital-first approach to engagement. Finally, key applications of bioactive peptides in cosmetics, functional foods, nutraceuticals, and pharmaceuticals further diversify the market. This integration of diverse segmentation criteria offers stakeholders a comprehensive view of value creation points and strategic opportunities available across various channels and product segments.

Based on Type, market is studied across Endogenous and Exogenous.

Based on Source, market is studied across Animal Derived, Dairy Sourced, Marine-Derived, and Plant-Based.

Based on Production Process, market is studied across Chemical Synthesis, Enzymatic Hydrolysis, and Recombinant Production.

Based on Function, market is studied across Antihypertensive, Antimicrobial, Antioxidant, and Immunomodulatory.

Based on Sales Channel, market is studied across Offline and Online. The Online is further studied across Brand Websites and E-Commerce Websites.

Based on Application, market is studied across Cosmetics, Functional Foods, Nutraceuticals, and Pharmaceuticals.

Global Regional Insights Highlighting Market Dynamics

A global perspective on the bioactive peptides market is essential to capture the heterogeneous growth patterns and localized dynamics driving regional advancements. Analysis indicates distinct variations across major regions including the Americas, Europe, Middle East & Africa, and Asia-Pacific. Each of these regions demonstrates unique consumption habits, regulatory environments, and R&D intensities that ultimately shape the market's evolution.

In the Americas, robust demand driven by preventive healthcare trends and well-established nutraceutical markets create a fertile landscape for bioactive peptides. Industry experts note that advancements in research and technical capabilities here pave the way for innovative applications in functional foods and pharmaceuticals. In contrast, the Europe, Middle East & Africa region is recognized for stringent regulatory standards paired with a consumer preference for natural and organic products. This has led to significant investments in sustainable production methods and product transparency, reflecting the region's commitment to quality and compliance.

Asia-Pacific stands out with its rapid industrialization and booming consumer market. The dynamic economic growth witnessed in this region is coupled with increasing awareness of health-promoting ingredients. As a result, R&D initiatives are robust and continuously contribute to the emergence of new product categories, positioning Asia-Pacific as a key driver of global market trends. Thus, these regional insights not only highlight divergent approaches to market development but also reveal converging themes of innovation, regulatory adaptation, and consumer-driven demand for integrated solutions.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Leading Companies Steering the Market Innovations

The competitive landscape of the bioactive peptides market is marked by the significant contributions of several industry-leading companies, each fostering innovation and guiding market evolution. Notable organizations such as Abbott Laboratories, Ajinomoto Co., Inc., and Amgen Inc. have consistently set high benchmarks through their commitment to advanced research and novel biotechnological applications. Alongside these, industry stalwarts like Archer Daniels Midland Company, Ashland Inc., and Bachem Holding AG have integrated cutting-edge production practices to enhance product quality and efficiency.

Major players including BASF SE and Cargill, Inc. are leveraging their extensive global networks and technical expertise to expand market reach, ensuring that high-quality bioactive peptides are accessible across varied geographies. Companies like Clariant AG and CPC Scientific Inc. have been instrumental in optimizing the synthesis and utility of these compounds, thereby driving the trend toward enhanced product performance. Croda International Plc, Eli Lilly and Company, alongside Evonik Industries AG and Ferring Pharmaceuticals, continue to innovate through strategic investments in research that target evolving consumer needs and new application frontiers.

Further, the contributions from GenScript Biotech Corporation, Givaudan, Glanbia plc, Koninklijke DSM N.V., and LipoTrue SL showcase a concerted effort to refine production processes and incorporate sustainability into their corporate practices. Leaders including Lonza Group, Merck & Co., Inc., Novo Nordisk A/S, and Novozymes A/S have effectively utilized their global expertise to set new standards in quality assurance and regulatory adherence. Emerging innovators such as PeptiDream Inc., Pfizer Inc., PolyPeptide Group, Protagonist Therapeutics, Inc., and Roquette Freres are also reshaping competitive dynamics through breakthrough discoveries, while established names like Symrise AG and Zealand Pharma continue to influence market directions with their strategic insights and diversified product portfolios. Collectively, these companies exemplify a vibrant mix of tradition, innovation, and responsiveness that drives the current momentum in the bioactive peptides market.

The report delves into recent significant developments in the Bioactive Peptides Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Ajinomoto Co., Inc., Amgen Inc., Archer Daniels Midland Company, Ashland Inc., Bachem Holding AG, BASF SE, Cargill, Inc., Clariant AG, CPC Scientific Inc., Croda International Plc, Eli Lilly and Company', Evonik Industries AG, Ferring Pharmaceuticals, GenScript Biotech Corporation, Givaudan, Glanbia plc, Koninklijke DSM N.V., LipoTrue SL, Lonza Group, Merck & Co., Inc., Novo Nordisk A/S, Novozymes A/S, PeptiDream Inc., Pfizer Inc., PolyPeptide Group, Protagonist Therapeutics, Inc., Roquette Freres, Symrise AG, and Zealand Pharma. Actionable Recommendations for Industry Leaders to Accelerate Growth

Industry leaders must take proactive steps to capitalize on the expanding opportunities in the bioactive peptides market by targeting areas that promise both short-term gains and long-term sustainability. First, it is imperative to invest in cutting-edge research and process optimization. By embracing innovative production techniques such as enzymatic hydrolysis and recombinant production, companies can enhance yield, ensure product purity, and reduce environmental impact.

In addition, an emphasis on robust supply chain diversification will enable organizations to better navigate unexpected market disruptions. A detailed understanding of segmentation, spanning from the type and source of peptides to their functional applications, allows for targeted product development and market penetration strategies. Companies should also focus on partnering with academic and industrial research centers to stay abreast of emerging trends and scientific breakthroughs.

Digital transformation plays a critical role in modern distribution channels, as evidenced by the growing prominence of online platforms. Enhancing digital marketing strategies and strengthening e-commerce capabilities will be fundamental in meeting the evolving distribution demands. Furthermore, aligning product portfolios with regional regulatory standards and consumer preferences is essential to gain a competitive edge across diverse markets. Finally, regular reassessments of market strategies, based on both macroeconomic trends and localized consumer behavior, will ensure that industry leaders remain agile and responsive in this dynamic marketplace.

Conclusion: Reiterating Opportunities Amid Evolving Trends

The evolution of the bioactive peptides market has introduced significant opportunities for innovation, product diversification, and strategic expansion. As scientific advancements continue to unlock the potential of these compounds, industry players are better equipped to meet the growing demand for functional ingredients that offer both health benefits and clinical applications. The interplay between evolving production methods, digital sales channels, and globally segmented consumer bases underlines a robust framework for future growth.

In summary, market trends and strategic shifts point to a future where tailored product offerings and innovative distribution approaches are paramount. Industry leaders who understand and utilize comprehensive segmentation insights will be well positioned to navigate the evolving competitive landscape. With new entry points emerging across the Americas, Europe, Middle East & Africa, and Asia-Pacific, the stage is set for continued expansion and enhanced market penetration.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing consumer awareness about the anti-aging properties of peptides
      • 5.1.1.2. Increased awareness of skin health fuels demand for products containing bioactive peptides
      • 5.1.1.3. Government regulations encouraging safe and effective skincare ingredients
    • 5.1.2. Restraints
      • 5.1.2.1. Concern associated with high production costs and complex manufacturing processes
    • 5.1.3. Opportunities
      • 5.1.3.1. Collaborating with dermatologists to scientifically substantiate bioactive peptide cosmetic claims
      • 5.1.3.2. Expanding bioactive peptide use in haircare products for scalp health and hair rejuvenation benefits
    • 5.1.4. Challenges
      • 5.1.4.1. Environmental concerns related to sourcing and processing bioactive peptides
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing adoption of exogenous peptides due to increased interest in nutritional supplements
    • 5.2.2. Application: Expanding application of bioactive peptides in the pharmaceutical sector
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bioactive Peptides Market, by Type

  • 6.1. Introduction
  • 6.2. Endogenous
  • 6.3. Exogenous

7. Bioactive Peptides Market, by Source

  • 7.1. Introduction
  • 7.2. Animal Derived
  • 7.3. Dairy Sourced
  • 7.4. Marine-Derived
  • 7.5. Plant-Based

8. Bioactive Peptides Market, by Production Process

  • 8.1. Introduction
  • 8.2. Chemical Synthesis
  • 8.3. Enzymatic Hydrolysis
  • 8.4. Recombinant Production

9. Bioactive Peptides Market, by Function

  • 9.1. Introduction
  • 9.2. Antihypertensive
  • 9.3. Antimicrobial
  • 9.4. Antioxidant
  • 9.5. Immunomodulatory

10. Bioactive Peptides Market, by Sales Channel

  • 10.1. Introduction
  • 10.2. Offline
  • 10.3. Online
    • 10.3.1. Brand Websites
    • 10.3.2. E-Commerce Websites

11. Bioactive Peptides Market, by Application

  • 11.1. Introduction
  • 11.2. Cosmetics
  • 11.3. Functional Foods
  • 11.4. Nutraceuticals
  • 11.5. Pharmaceuticals

12. Americas Bioactive Peptides Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Bioactive Peptides Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Bioactive Peptides Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Nuritas secured USD 42 million in a Series C funding round
    • 15.3.2. Evolved By Nature introduced Activated Silk 8A-????, a bioactive peptide
    • 15.3.3. Designs for Health introduced Performance Peptides for enhancing muscle strength and recovery
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Ajinomoto Co., Inc.
  • 3. Amgen Inc.
  • 4. Archer Daniels Midland Company
  • 5. Ashland Inc.
  • 6. Bachem Holding AG
  • 7. BASF SE
  • 8. Cargill, Inc.
  • 9. Clariant AG
  • 10. CPC Scientific Inc.
  • 11. Croda International Plc
  • 12. Eli Lilly and Company'
  • 13. Evonik Industries AG
  • 14. Ferring Pharmaceuticals
  • 15. GenScript Biotech Corporation
  • 16. Givaudan
  • 17. Glanbia plc
  • 18. Koninklijke DSM N.V.
  • 19. LipoTrue SL
  • 20. Lonza Group
  • 21. Merck & Co., Inc.
  • 22. Novo Nordisk A/S
  • 23. Novozymes A/S
  • 24. PeptiDream Inc.
  • 25. Pfizer Inc.
  • 26. PolyPeptide Group
  • 27. Protagonist Therapeutics, Inc.
  • 28. Roquette Freres
  • 29. Symrise AG
  • 30. Zealand Pharma

LIST OF FIGURES

  • FIGURE 1. BIOACTIVE PEPTIDES MARKET MULTI-CURRENCY
  • FIGURE 2. BIOACTIVE PEPTIDES MARKET MULTI-LANGUAGE
  • FIGURE 3. BIOACTIVE PEPTIDES MARKET RESEARCH PROCESS
  • FIGURE 4. BIOACTIVE PEPTIDES MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 19. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 23. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 28. BIOACTIVE PEPTIDES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 29. BIOACTIVE PEPTIDES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIOACTIVE PEPTIDES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOACTIVE PEPTIDES MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY ENDOGENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY EXOGENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY ANIMAL DERIVED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY DAIRY SOURCED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY MARINE-DERIVED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY PLANT-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY ENZYMATIC HYDROLYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY RECOMBINANT PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY ANTIHYPERTENSIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY ANTIMICROBIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY ANTIOXIDANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY IMMUNOMODULATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY BRAND WEBSITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY E-COMMERCE WEBSITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTIONAL FOODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL BIOACTIVE PEPTIDES MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES BIOACTIVE PEPTIDES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED KINGDOM BIOACTIVE PEPTIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM BIOACTIVE PEPTIDES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM BIOACTIVE PEPTIDES MARKET SIZE, BY PRODUCTION PROCESS, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM BIOACTIVE PEPTIDES MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM BIOACTIVE PEPTIDES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM BIOACTIVE PEPTIDES MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM BIOACTIVE PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 326. BIOACTIVE PEPTIDES MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 327. BIOACTIVE PEPTIDES MARKET, FPNV POSITIONING MATRIX, 2024